Philippe Laffont
CAI

Philippe Laffont’s Caris Life Sciences CAI Stock Holding History

Philippe Laffont’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$176M Hold
9,819,992
– – 0.6% 31
2025
Q4 		$265M Sell
9,819,992
-322,206
-3% -$9.07M 0.66% 30
2025
Q3 		$307M Hold
10,142,198
– – 0.75% 33
2025
Q2 		$271M Buy
+10,142,198
New +$273M 0.75% 30

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $326M AUM
SSP
Sixth Street Partners Dallas, Texas $711M AUM 9.3% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Philippe Laffont's CAI Position: Q1 2026 in Review

Philippe Laffont held its Caris Life Sciences (CAI) position steady in Q1 2026 at 9,819,992 shares worth $176M. The position accounts for 0.6% of the portfolio, ranked #31.

Philippe Laffont first reported a position in CAI in Q2 2025 and has held it in 4 quarters since. The position peaked at $307M in Q3 2025. 202 funds tracked by Wall St. Rank hold CAI as of Q1 2026.

  • Philippe Laffont held 9,819,992 shares of Caris Life Sciences worth $176M as of Q1 2026.
  • Philippe Laffont left its Caris Life Sciences share count unchanged in Q1 2026.
  • Caris Life Sciences made up 0.6% of Philippe Laffont's portfolio in Q1 2026, its #31 holding.
  • Philippe Laffont first reported a position in Caris Life Sciences in Q2 2025 and has held it in 4 quarters since.
  • Philippe Laffont's Caris Life Sciences position peaked at $307M in Q3 2025.
  • 202 funds tracked by Wall St. Rank held Caris Life Sciences as of Q1 2026.

Based on Coatue Management's 13F filing for Q1 2026, filed 15 May 2026.